Technical Analysis for NVCN - Neovasc Inc.

Grade Last Price % Change Price Change
grade B 2.87 -2.71% -0.08
NVCN closed down 2.71 percent on Friday, August 23, 2019, on 8 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical NVCN trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
20 DMA Support Bullish -2.71%
Pocket Pivot Bullish Swing Setup -2.71%
Doji - Bullish? Reversal -2.71%
Up 3 Days in a Row Strength -5.28%
Crossed Above 20 DMA Bullish -2.71%
Inside Day Range Contraction -2.71%
20 DMA Resistance Bearish -0.69%
Wide Bands Range Expansion -0.69%

Older signals for NVCN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular products worldwide. Its products include the Neovasc Reducer for the treatment of refractory angina; and Tiara technology in development for the transcatheter treatment of mitral valve disease. The company also develops and manufactures the PeriPatch, a line of biological tissue products for use in third-party medical products, including transcatheter heart valves. In addition, the company provides a range of custom Peripatch products to industry customers for incorporation into their own products; and consulting and original equipment manufacturing services to other medical device companies. Further, it offers pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Medicine Medical Specialties Medical Devices Circulatory System Interventional Cardiology Cardiac Surgery Cardiovascular Products Cardiovascular Edwards Lifesciences Heart Valve Valvular Heart Disease
Is NVCN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.23
52 Week Low 0.372
Average Volume 614,321
200-Day Moving Average 1.1769
50-Day Moving Average 2.7041
20-Day Moving Average 2.887
10-Day Moving Average 2.929
Average True Range 0.2601
ADX 16.64
+DI 22.4695
-DI 20.2247
Chandelier Exit (Long, 3 ATRs ) 2.507
Chandelier Exit (Short, 3 ATRs ) 3.1203
Upper Bollinger Band 3.1838
Lower Bollinger Band 2.5902
Percent B (%b) 0.47
BandWidth 20.561136
MACD Line 0.0298
MACD Signal Line 0.058
MACD Histogram -0.0281
Fundamentals Value
Market Cap 226.47 Million
Num Shares 78.9 Million
EPS -0.07
Price-to-Earnings (P/E) Ratio -41.00
Price-to-Sales 13.79
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.17
Resistance 3 (R3) 3.18 3.10 3.12
Resistance 2 (R2) 3.10 3.02 3.09 3.10
Resistance 1 (R1) 2.98 2.97 2.94 2.97 3.09
Pivot Point 2.90 2.90 2.88 2.89 2.90
Support 1 (S1) 2.78 2.82 2.74 2.77 2.65
Support 2 (S2) 2.70 2.77 2.69 2.64
Support 3 (S3) 2.58 2.70 2.62
Support 4 (S4) 2.57